CIK 0001724521 · Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473898435
- Phone
- (510) 694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | KANEKO YASUNORI Director | Grant or award | +5,700 | 25,700 | ||
| 2026-06-11 | KANEKO YASUNORI Director | Grant or award · Stock Option (Right to Buy) | +16,900 | 16,900 | ||
| 2026-06-11 | FALBERG KATHRYN E Director | Grant or award | +5,700 | 44,300 | ||
| 2026-06-11 | FALBERG KATHRYN E Director | Grant or award · Stock Option (Right to Buy) | +16,900 | 16,900 | ||
| 2026-06-11 | PERLMAN ANDREW J Director | Grant or award | +5,700 | 48,325 | ||
| 2026-06-11 | PERLMAN ANDREW J Director | Grant or award · Stock Option (Right to Buy) | +16,900 | 16,900 | ||
| 2026-06-01 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −2,562 | $25.77 | $66K | 39,581 |
| 2026-05-11 | Goeltz II Robert C. Chief Financial Officer | Sale 10b5-1 | −7,763 | $25.63 | $199K | 84,161 |
| 2026-01-23 | Markus Richard Chief Medical Officer | Grant or award | +24,000 | 89,647 | ||
| 2026-01-23 | Markus Richard Chief Medical Officer | Grant or award · Stock Option (right to buy) | +96,000 | 96,000 | ||
| 2026-01-23 | Tang Carolyn C. General Counsel | Grant or award | +24,000 | 148,734 | ||
| 2026-01-23 | Tang Carolyn C. General Counsel | Grant or award · Stock Option (right to buy) | +96,000 | 96,000 | ||
| 2026-01-23 | Azoy Alexander Chief Accounting Officer | Grant or award | +21,050 | 39,581 | ||
| 2026-01-23 | Azoy Alexander Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +14,050 | 14,050 | ||
| 2026-01-23 | Jarrett Jennifer Chief Operating Officer | Grant or award | +31,000 | 224,024 | ||
| 2026-01-23 | Jarrett Jennifer Chief Operating Officer | Grant or award · Stock Option (right to buy) | +126,000 | 126,000 | ||
| 2026-01-23 | Goeltz II Robert C. Chief Financial Officer | Grant or award | +24,000 | 91,924 | ||
| 2026-01-23 | Goeltz II Robert C. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +96,000 | 96,000 | ||
| 2026-01-23 | Jaen Juan C. President | Grant or award | +31,000 | 377,012 | ||
| 2026-01-23 | Jaen Juan C. President | Grant or award · Stock Option (right to buy) | +126,000 | 126,000 |
Page 2 of 9 · 177 trades